LEADER 03610nam  2200529 a 450 
001 9910462723803321
005 20200520144314.0
010   $a1-60876-695-0
035   $a(CKB)2670000000369202
035   $a(EBL)3022166
035   $a(SSID)ssj0000871641
035   $a(PQKBManifestationID)12403160
035   $a(PQKBTitleCode)TC0000871641
035   $a(PQKBWorkID)10823845
035   $a(PQKB)10361407
035   $a(MiAaPQ)EBC3022166
035   $a(Au-PeEL)EBL3022166
035   $a(CaPaEBR)ebr10693631
035   $a(OCoLC)923667943
035   $a(EXLCZ)992670000000369202
100   $a20050126d2009      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aOvarian cancer$b[electronic resource] $enew research /$fA.P. Bardos, editor
210   $aNew York $cNova Biomedical Books$d2009
215   $a1 online resource (313 p.)
225 1 $aHorizons in cancer research series ;$vv. 19
300   $aDescription based upon print version of record.
311   $a1-59454-241-4 
320   $aIncludes bibliographical references and index.
327   $ach. 1. Progress in ovarian cancer research / Dilek Aktas -- ch. 2. Ovulation and ovarian surface epithelial cancer / William J. Murdoch and Anna C. McDonnel -- ch. 3. Ovarian sertoli-leydig cell tumors with heterologous elements / Evanthia Kostopoulou and Alexander Talerman -- ch. 4. Interleukin-1 system and sex steroid receptor gene expression in human endometrial cancer / G. Hudelist ... [et al.] -- ch. 5. Role of membrane-associated serine/threonine phosphatase in ovarian cancer cell survival : evidence for minor role of apoptosis in gonadotropin-releasing hormone's antiproliferative signaling / Atsushi Imai ... [et al.] -- ch. 6. Docetaxel in combination with carboplatin as first-line chemotherapy for patients with epithelial ovarian cancer / Yoichi Aoki and Kenichi Tanaka -- ch. 7. Immunospecific albumin microspheres as delivery system for cisplatin and 5-fluorouracil for the treatment of ovarian adenocarcinoma / Ernest J. Truter and Aldina S. Santos -- ch. 8. Strategies for improving outcome in ovarian cancer : the role of surgery / Karsten Mu?nstedt ... [et al.] -- ch. 9. Should systematic lymphadenectomy be performed in suboptimally debulked patients with stage III ovarian carcinoma? : a Degog study / Ugar Syagili ... [et al.] -- ch. 10. Outcomes for surgery in ovarian cancer / L. Elit -- ch. 11. Do ascites, mass volume and peritoneal carcinomatosis affect serum CA-125 levels in patients with ovarian carcinoma? : a different point of view / Ugar Saygili ... [et al.] -- ch. 12. The usefulness of serum CA-125 levels in the prediction of optimal primary cytoreduction in patients with advanced ovarian carcinoma / Ugar Syagili, Serkan Guclu and Oktay Erten -- ch. 13. Perceived risk of ovarian cancer, worry about ovarian cancer risk, and use of ovarian cancer screening by women at risk for ovarian cancer / M. Robyn Andersen ... [et al.] -- ch. 14. New strategy for the treatment of ovarian cancer with the aim to conquer chemoresistance / Junzo Kigawa ... [et al.] -- ch. 15. Treatment decision making in ovarian cancer / L. Elit.
410  0$aHorizons in cancer research ;$vv. 19.
606   $aOvaries$xCancer
608   $aElectronic books.
615  0$aOvaries$xCancer.
676   $a616.99/465
701   $aBardos$b A. P$0963018
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910462723803321
996   $aOvarian cancer$92183588
997   $aUNINA